Back to Search
AAMIR RAZA, M.D.
M.D.
Nephrology Physician
NPI: 1578710158IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
4301092334(MI)
Nephrology PhysicianPrimary
Internal Medicine — Nephrology
Code: 207RN0300X
A126345(CA)
CMS Specialties
PrimaryNEPHROLOGY
Education
OTHER
Class of 2004
Research & Publications (20)
Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome.
PMID 19439093·J Hematol Oncol·2009
3-trial
Complete remissions observed in acute myeloid leukemia following prolonged exposure to lintuzumab: a phase 1 trial.
PMID 19557623·Leuk Lymphoma·2009
3-trial
Phase 1 multicenter dose-escalation study of ezatiostat hydrochloride (TLK199 tablets), a novel glutathione analog prodrug, in patients with myelodysplastic syndrome.
PMID 19398716·Blood·2009
3-trial
Characterization of a novel dithiocarbamate glutathione reductase inhibitor and its use as a tool to modulate intracellular glutathione.
PMID 19049979·J Biol Chem·2009
8-other
Design and synthesis of sulfoximine based inhibitors for HIV-1 protease.
PMID 18829317·Bioorg Med Chem Lett·2008
8-other
Combination of 5-azacytidine and thalidomide for the treatment of myelodysplastic syndromes and acute myeloid leukemia.
PMID 18720364·Cancer·2008
8-other
Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1 risk myelodysplastic syndromes with karyotypes other than deletion 5q.
PMID 17893227·Blood·2008
3-trial
Development and application of spectrophotometric methods for the determination of citalopram hydrobromide in dosage forms.
PMID 16595940·Chem Pharm Bull (Tokyo)·2006
8-other
Phase II study of topotecan and thalidomide in patients with high-risk myelodysplastic syndromes.
PMID 16396766·Leuk Lymphoma·2006
3-trial
Remicade as TNF suppressor in patients with myelodysplastic syndromes.
PMID 15370256·Leuk Lymphoma·2004
3-trial
Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 expression.
PMID 15203277·Leuk Res·2004
5-case
Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromes.
PMID 11493439·Blood·2001
3-trial
What the human genome project will not tell us: the role of micro-organisms in disease.
PMID 11166834·Leuk Res·2001
8-other
Consilience across evolving dysplasias affecting myeloid, cervical, esophageal, gastric and liver cells: common themes and emerging patterns.
PMID 10634648·Leuk Res·2000
6-review
Myelodysplastic syndromes may have an infectious etiology.
PMID 11086944·J Toxicol Environ Health A·2000
7-preclinical
Anti-TNF therapies in rheumatoid arthritis, Crohn's disease, sepsis, and myelodysplastic syndromes.
PMID 10891888·Microsc Res Tech·2000
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 4297 N Sierra Way Ste A
San Bernardino, CA 92407 - Phone
- (909) 300-0901
Quick Facts
- NPI
- 1578710158
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 22
- Publications
- 20
Are you this provider?
Claim Your Profile